From: Effects of Chinese medicine for COVID-19 rehabilitation: a multicenter observational study
Clinical symptoms | No. of occurrence | % among participants |
---|---|---|
Fever | 89 | 59.33 |
Fatigue / Tiredness | 83 | 55.33 |
Dry cough | 70 | 46.67 |
Muscle / Joint pain | 49 | 32.67 |
Headache | 42 | 28.00 |
Coughing up phlegm | 40 | 26.67 |
Sore throat | 39 | 25.26 |
Loss of taste | 36 | 24.00 |
Loss of smell | 36 | 24.00 |
Shortness of breath | 35 | 23.33 |
Diarrhoea | 33 | 22.00 |
Aversion to cold | 31 | 20.67 |
Poor appetite | 27 | 18.00 |
Runny nose | 26 | 17.33 |
Stuffy nose | 21 | 14.00 |
Night sweats | 18 | 12.00 |
Soreness and weakness of waist and knees | 15 | 10.00 |
Spontaneous sweating | 14 | 9.33 |
Feverish palms and soles | 12 | 8.00 |
Nausea/Vomit | 6 | 4.00 |
Rash | 6 | 4.00 |
Tinnitus | 5 | 3.33 |
Coughed up blood | 1 | 0.67 |
Conjunctival hyperemia | 1 | 0.67 |
Chronic illness | No. of occurrence | % among participants |
---|---|---|
Hypertension | 36 | 24.00 |
High Cholesterol | 22 | 14.67 |
Diabetes mellitus | 19 | 12.67 |
Rhinitis | 15 | 10.00 |
Heart Disease | 9 | 6.00 |
HBV | 9 | 6.00 |
Gallbladder Disease | 8 | 5.33 |
History of Cancer | 7 | 4.67 |
Eczema | 7 | 4.67 |
Asthma | 6 | 4.00 |
Immunodeficiency | 5 | 3.33 |
Fatty Liver Disease | 5 | 3.33 |
Depression | 5 | 3.33 |
Thyroid Disease | 5 | 3.33 |
Others | 12 | 8.00 |
 Sleep apnea | 3 | 2.00 |
 Gastritis | 2 | 1.3 |
 Thalassemia | 1 | 0.6 |
 Gout | 1 | 0.6 |
 Benignant goiter | 1 | 0.6 |
 History of parotidectomy | 1 | 0.6 |
 History of rhinitis surgery | 1 | 0.6 |
 Recovered from tuberculosis | 1 | 0.6 |
 Anaemia | 1 | 0.6 |
 Uterine fibroids | 1 | 0.6 |
 Pulmonary fibrosis | 1 | 0.6 |
 Hirschsprung’s disease | 1 | 0.6 |